Intrinsiqq
Goldenwell Biotech Inc. logo

Goldenwell Biotech Inc.

GWLL

Compare
⚠ Showing the latest available close (Nov 19, 2026, 3 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$59M
EPS$0.00
P/E2106.09
P/FCF–
EV/EBITDA-501.49
FCF Yield–
Div. Yield–
Net Debt/FCF–
Goldenwell Biotech Inc. intrinsic value
52-Week Range
$0.51$1.45

Profitability & Returns

Revenue (TTM)

$55.00

▼ -60.4% YoY

Net Income (TTM)

-$286K

▼ -125.5% YoY

Op. Margin

-215356.36%

▼ -117487.6pp YoY

ROIC

-102.91%

▼ -39.2pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$105K

▲ +81.6% YoY

Net Debt

-$788.00

Net Cash Position

Cash & Equiv.

$788.00

Continue Research

Goldenwell Biotech (GWLL) in four numbers

Fair value (revenue)
$0.00
Price $0.60 is 193261106% above it.
Intrinsic Value
Quality score
22/100
Best check: net debt, -$788. Weakest: return on capital, -102.9%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
2106.09
From the last twelve months of earnings.
Financials

Questions about Goldenwell Biotech

Is Goldenwell Biotech (GWLL) overvalued?

At $0.60, Goldenwell Biotech's price is 193261106% above the $0.00 a share fair value that Intrinsiqq's calculator gets from its revenue. It trades at 2106.09 times earnings. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Goldenwell Biotech's fair value?

Intrinsiqq's calculator puts Goldenwell Biotech's fair value at $0.00 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 0.9, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.00. Every input can be changed on the Intrinsic Value tab.

Is Goldenwell Biotech a high-quality business?

Goldenwell Biotech scores 22 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is net debt at -$788, and its weakest is return on capital at -102.9%. The Quality tab shows every check against its target.

Does Goldenwell Biotech (GWLL) pay a dividend?

No. Goldenwell Biotech (GWLL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 9 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in GWLL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GWLL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.